Vol. 29.Issue. 6. November - December 2017 | Clínica e Investigación en Arteriosclerosis

ISSN: 0214-9168

Clínica e Investigación en Arteriosclerosis ha recibido Factor de Impacto (JCR) por primera vez en 2023. Guía para autores - Envío de manuscritos

"Notas metodológicas": una nueva e importante sección en Clínica e Investigación en Arteriosclerosis

Indexed in:

Web of Science, Index Medicus/MEDLINE, Scopus, IBECS, IME, MEDES

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

1.9

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.2

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.424

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.435

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 29. Issue 6.

Pages 231-280 (November - December 2017)

Originales

Mercury exposure induces proinflammatory enzymes in vascular fibroblasts

Alberto Millán Longo, Óscar Montero Saiz, Claudia Sarró Fuente, Andrea Aguado Martínez, Mercedes Salaices Sánchez

Clin Invest Arterioscl. 2017;29:231-8

Full text access

Open Article

Improvement of serum lipids concentration in a general population historical cohort. Why?

Juan Antonio Gómez Gerique, Ignacio Ferreira Gonzalez, Miguel Angel Rubio Herrera, David Lora Pablos, Beatriz Martín Ballesteros, Romina García Sardina, Agustín Gómez de la Cámara

Clin Invest Arterioscl. 2017;29:239-47

Full text access

Open Article